163 related articles for article (PubMed ID: 37591290)
21. Therapy of patients with IgA-nephropathy: a critical appraisal.
Floege J; Mertens P
Kidney Blood Press Res; 2000; 23(3-5):207-9. PubMed ID: 11031723
[No Abstract] [Full Text] [Related]
22. IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis.
Segawa Y; Ishida R; Kanehisa F; Nakai K; Morimoto M; Seno M; Nakayama M; Kusaba T; Katoh N; Tamagaki K
BMC Nephrol; 2020 Aug; 21(1):366. PubMed ID: 32842976
[TBL] [Abstract][Full Text] [Related]
23. To treat or not to treat IgA nephropathy? That is the question!
Appel GB
Clin J Am Soc Nephrol; 2006 May; 1(3):347-8. PubMed ID: 17699228
[No Abstract] [Full Text] [Related]
24. [Advances in the treatment of progressive renal dysfunction. 2. IgA nephropathy].
Kawamura T; Ito Y; Ogura M; Utsunomiya Y
Nihon Naika Gakkai Zasshi; 2004 May; 93(5):912-22. PubMed ID: 15176246
[No Abstract] [Full Text] [Related]
25. Idiopathic glomerulonephritis: is it IgA nephropathy?
Erickson P
ANNA J; 1993 Apr; 20(2):127-32, 153. PubMed ID: 8512371
[TBL] [Abstract][Full Text] [Related]
26. A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study.
Hogg RJ
Am J Kidney Dis; 1995 Nov; 26(5):792-6. PubMed ID: 7485134
[No Abstract] [Full Text] [Related]
27. Evidence-based clinical practice guidelines for IgA nephropathy 2014.
Yuzawa Y; Yamamoto R; Takahashi K; Katafuchi R; Tomita M; Fujigaki Y; Kitamura H; Goto M; Yasuda T; Sato M; Urushihara M; Kondo S; Kagami S; Yasuda Y; Komatsu H; Takahara M; Harabuchi Y; Kimura K; Matsuo S
Clin Exp Nephrol; 2016 Aug; 20(4):511-535. PubMed ID: 27095365
[No Abstract] [Full Text] [Related]
28. IgA nephropathy: recent developments.
Floege J; Feehally J
J Am Soc Nephrol; 2000 Dec; 11(12):2395-2403. PubMed ID: 11095664
[No Abstract] [Full Text] [Related]
29. Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathy.
Tomino Y
Nephrology (Carlton); 2010 Feb; 15(1):1-6. PubMed ID: 20377762
[TBL] [Abstract][Full Text] [Related]
30. Importance of the duration of nephropathy prior to tonsillectomy and steroid pulse therapy in IgA nephropathy patients.
Ieiri N; Osamu H
Clin Exp Nephrol; 2015 Apr; 19(2):325. PubMed ID: 25362523
[No Abstract] [Full Text] [Related]
31. Treatment of IgA nephropathy.
Lin CY
Springer Semin Immunopathol; 1994; 16(1):121-7. PubMed ID: 7997942
[No Abstract] [Full Text] [Related]
32. Recurrence of IgA nephropathy in renal allografts.
Berger J
Am J Kidney Dis; 1988 Nov; 12(5):371-2. PubMed ID: 3055960
[TBL] [Abstract][Full Text] [Related]
33. New insight into the management of IgA nephropathy.
Zou Y; Yang M; Du X
Clin Exp Nephrol; 2018 Dec; 22(6):1442-1443. PubMed ID: 29536391
[No Abstract] [Full Text] [Related]
34. Immunosuppression in IgA nephropathy: how certain are we?
Floege J; Rauen T
Kidney Int; 2016 Jan; 89(1):9-11. PubMed ID: 26759037
[TBL] [Abstract][Full Text] [Related]
35. The treatment of IgA nephropathy: status at the end of the millenium.
Glassock RJ
J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
[TBL] [Abstract][Full Text] [Related]
36. Can a dysregulated mucosal immune system in IgA nephropathy be controlled by tonsillectomy?
Coppo R
Nephrol Dial Transplant; 2010 Aug; 25(8):2395-7. PubMed ID: 20488821
[No Abstract] [Full Text] [Related]
37. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis.
Emancipator SN; Lamm ME
Lab Invest; 1989 Feb; 60(2):168-83. PubMed ID: 2644483
[No Abstract] [Full Text] [Related]
38. IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated?
Praga M; Caravaca F; Yuste C; Cavero T; Hernández E; Morales E; Mérida E; Moreno JA; Sevillano A; Gutiérrez E
Nefrologia (Engl Ed); 2018; 38(4):347-352. PubMed ID: 29636281
[No Abstract] [Full Text] [Related]
39. Early start of intensive therapy in malignant form of IgA nephropathy.
Boobes Y; Baz M; Durand C; Jaber K; Goldstein P; Berland Y
Nephron; 1990; 54(4):351-3. PubMed ID: 2325803
[No Abstract] [Full Text] [Related]
40. New diagnostic and therapeutic aspects in IgA nephropathy.
Floege J
Kidney Blood Press Res; 1998; 21(2-4):283-5. PubMed ID: 9762858
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
